A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer

NCT02038699 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Protocol not activated.

Conditions

Advanced Glioblastoma
Advanced Colorectal Cancer
Advanced Triple-negative Breast Cancer
Advanced Non-small Cell Lung Cancer

Interventions

DRUG: ONC201

Sponsor

Jazz Pharmaceuticals